The prognostic impact of TP53 comutation in EGFR mutant lung cancer patients: a systematic review and meta-analysis.

Conclusion Generally we confirmed the prognostic value of poor OS and PFS of TP53 commutation in EGFR mutant lung cancers and it should be further investigated and validated regarding to the prognostic role of TP53 mutation subtypes. PMID: 30798634 [PubMed - as supplied by publisher]
Source: Postgraduate Medicine - Category: Internal Medicine Tags: Postgrad Med Source Type: research